Due Diligence and Art

Due Diligence and Art

TrumpRx + BlinkRx: self dealing by Trump family x2!

In other news, WSJ rediscovered journalism

Sasha Latypova's avatar
Sasha Latypova
Oct 08, 2025
∙ Paid

Dear readers, I wrote about Trump self dealing via the Pfizer-TrumpRx direct to consumer drug sales just the other day:

The Art of the Drug Deal: Pfizer may funnel up to ~$500M to Trump Organization via TrumpRx.

The Art of the Drug Deal: Pfizer may funnel up to ~$500M to Trump Organization via TrumpRx.

Sasha Latypova
·
September 30, 2025
Read full story
TrumpRx deal: Congress must demand disclosure of the Trump trademark licensing arrangement.

TrumpRx deal: Congress must demand disclosure of the Trump trademark licensing arrangement.

Sasha Latypova
·
October 6, 2025
Read full story

… but I underestimated the scope of self dealing by Trump. I thought he was “just” skimming off the top for his name licensing. Well, the 5D chess grossmeister that he is, he is skimming off the top not once but twice: once for him (T…

User's avatar

Continue reading this post for free, courtesy of Sasha Latypova.

Or purchase a paid subscription.
© 2026 Sasha Latypova · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture